4-Valent HPV Vaccine: A ground-breaking product offering broad protection against HPV Types 6, 11, 16, 18. Targets females aged 9 to 26 years. May prevent cervical, vulvar, and vaginal cancer, pre-cancerous lesions, and genital warts.
Highlights of the product include:
The 4-Valent Human Papillomavirus (HPV) Vaccine is a medical leap in the field of preventive healthcare, providing comprehensive protection against HPV-related cancers and diseases. This innovative recombinant vaccine is designed to offer immunity against diseases primarily caused by four prevalent HPV types 6, 11, 16, and 18. This includes cervical, vulvar, and vaginal cancers, as well as pre-cancerous or dysplastic lesions, genital warts, and persistent infections.
For an all-inclusive understanding of the vaccine specifications and the recommended usage, we advise visiting the 'Prequalified Vaccines' section on the World Health Organization (WHO) website. Our 4-valent HPV vaccine promises a proactive approach to health, offering robust protection against HPV-related complications with certified safety.